Annals of Oncology 13:1007-1015, 2002
© 2002 European Society for Medical Oncology
Review Article |
Nasopharyngeal carcinoma
Prince of Wales Hospital, Sir Y. K. Pao Cancer Center, Chinese University of Hong Kong, People’s Republic of China
Received 20 December 2001; revised and accepted 8 February 2002
Abstract
Nasopharyngeal carcinoma (NPC) is endemic in southern China where genetic abnormalities and Epstein–Barr virus (EBV) infection are critical in the pathogenesis of the disease. Circulating EBV-DNA has been shown to improve prognostication and monitoring of NPC patients. Radiotherapy is the mainstay treatment for early disease and concurrent cisplatin/radiotherapy has been demonstrated to prolong survival in locoregionally advanced disease. Ongoing studies of targeting agents and immunotherapeutic approaches may further improve treatment results.
Key words: Epstein–Barr virus, nasopharyngeal carcinoma, review, treatment
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. U. Louis, K. Straathof, C. M. Bollard, C. Gerken, M. H. Huls, M. V. Gresik, M.-F. Wu, H. L. Weiss, A. P. Gee, M. K. Brenner, et al. Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients Blood, March 12, 2009; 113(11): 2442 - 2450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Fogg, L. J. Wirth, M. Posner, and F. Wang Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma PNAS, March 3, 2009; 106(9): 3318 - 3323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-S. Wang, C.-Y. Chang, S.-E. Chow, Y.-W. Chen, and C.-M. Yang Exercise modulates platelet-nasopharyngeal carcinoma cell aggregation and subsequent tissue factor and matrix metalloproteinase activities J Appl Physiol, September 1, 2007; 103(3): 763 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T.-C. Chang, S.-H. Chan, C.-Y. Lin, T.-Y. Lin, H.-M. Wang, C.-T. Liao, T.-H. Wang, L.-Y. Lee, and A.-J. Cheng Differentially expressed genes in radioresistant nasopharyngeal cancer cells: gp96 and GDF15 Mol. Cancer Ther., August 1, 2007; 6(8): 2271 - 2279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-M. Sun, C. I. Li, E.-Y. Huang, and T. L. Vaughan Survival Differences by Race in Nasopharyngeal Carcinoma Am. J. Epidemiol., February 1, 2007; 165(3): 271 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. N. Heller, J. Upshaw, B. Seyoum, H. Zebroski, and C. Munz Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers Blood, February 1, 2007; 109(3): 1138 - 1146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-N. Qian, B. Berghuis, G. Tsarfaty, M. Bruch, E. J. Kort, J. Ditlev, I. Tsarfaty, E. Hudson, D. G. Jackson, D. Petillo, et al. Preparing the "Soil": The Primary Tumor Induces Vasculature Reorganization in the Sentinel Lymph Node before the Arrival of Metastatic Cancer Cells Cancer Res., November 1, 2006; 66(21): 10365 - 10376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Richey, A. F. Olshan, J. George, C. G. Shores, A. M. Zanation, T. Cannon, and M. C. Weissler Incidence and survival rates for young blacks with nasopharyngeal carcinoma in the United States. Arch Otolaryngol Head Neck Surg, October 1, 2006; 132(10): 1035 - 1040. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Tai, M. Lin, F. Chang, G. Chen, F. Hsiao, N. Sutkowski, and B. T. Huber Murine Vbeta3+ and Vbeta7+ T Cell Subsets Are Specific Targets for the HERV-K18 Env Superantigen. J. Immunol., September 1, 2006; 177(5): 3178 - 3184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Comoli, P. Pedrazzoli, R. Maccario, S. Basso, O. Carminati, M. Labirio, R. Schiavo, S. Secondino, C. Frasson, C. Perotti, et al. Cell Therapy of Stage IV Nasopharyngeal Carcinoma With Autologous Epstein-Barr Virus-Targeted Cytotoxic T Lymphocytes J. Clin. Oncol., December 10, 2005; 23(35): 8942 - 8949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Straathof, A. M. Leen, E. L. Buza, G. Taylor, M. H. Huls, H. E. Heslop, C. M. Rooney, and C. M. Bollard Characterization of Latent Membrane Protein 2 Specificity in CTL Lines from Patients with EBV-Positive Nasopharyngeal Carcinoma and Lymphoma J. Immunol., September 15, 2005; 175(6): 4137 - 4147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. M. Straathof, C. M. Bollard, U. Popat, M. H. Huls, T. Lopez, M. C. Morriss, M. V. Gresik, A. P. Gee, H. V. Russell, M. K. Brenner, et al. Treatment of nasopharyngeal carcinoma with Epstein-Barr virus-specific T lymphocytes Blood, March 1, 2005; 105(5): 1898 - 1904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.A. Langendijk, Ch.R. Leemans, J. Buter, J. Berkhof, and B.J. Slotman The Additional Value of Chemotherapy to Radiotherapy in Locally Advanced Nasopharyngeal Carcinoma: A Meta-Analysis of the Published Literature J. Clin. Oncol., November 15, 2004; 22(22): 4604 - 4612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Xiong, Z. Y. Zeng, J. H. Xia, K. Xia, S. R. Shen, X. L. Li, D. X. Hu, C. Tan, J. J. Xiang, J. Zhou, et al. A Susceptibility Locus at Chromosome 3p21 Linked to Familial Nasopharyngeal Carcinoma Cancer Res., March 15, 2004; 64(6): 1972 - 1974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Kerr A little citadel of light in a malignant sea of darkness Ann. Onc., January 1, 2004; 15(1): 1 - 2. [Full Text] [PDF]
|
|
|
|
|
|
P. Comoli, R. De Palma, S. Siena, A. Nocera, S. Basso, F. Del Galdo, R. Schiavo, O. Carminati, A. Tagliamacco, G. F. Abbate, et al. Adoptive transfer of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T cells with in vitro antitumor activity boosts LMP2-specific immune response in a patient with EBV-related nasopharyngeal carcinoma Ann. Onc., January 1, 2004; 15(1): 113 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Cackett, J. Stebbing, and B. Dhillon Complications of Therapy and a Diagnostic Dilemma Case: CASE 1. RADIATION MACULOPATHY FOLLOWING TREATMENT OF NASOPHARYNGEAL CARCINOMA J. Clin. Oncol., December 15, 2003; 21(24): 4650 - 4651. [Full Text] [PDF]
|
|